
Yu-Han Chen
Credentials: ·
History
- 2023–2026
- 2019–2023
Research
Review · Diagnostics · 2024 · First of 11 authors · 8 citations
Systematic review or meta-analysis · Antimicrobial Agents and Chemotherapy · 2025 · First of 10 authors · 6 citations
Erythrocytosis and thromboembolic risks associated with SGLT2 inhibitors in type 2 diabetes
Scientific Reports · 2025 · First of 9 authors · 3 citations

3 papers

3 papers

2 papers

2 papers · 2 as a resident

2 papers

2 papers

2 papers · 2 as a fellow

2 papers · 2 as a resident

